Letermovir
1 paper2 findings
Outcomes
2Frailty
downin humans1
1 study
Frailty
downin humans1
Letermovir decreases frailty in humans.
“improve immune and frailty outcomes in PWH”
Reviewin people with HIV
Cytomegalovirus in HIV: A Modifiable Driver of Inflammation, Frailty, and Aging
Current HIV/AIDS reports20 Mar 2026
Inflammation
downin humans1
1 study
Inflammation
downin humans1
Letermovir decreases inflammation in humans.
“Early interventional data indicate that letermovir can reduce inflammation”
Reviewin people with HIV
Cytomegalovirus in HIV: A Modifiable Driver of Inflammation, Frailty, and Aging
Current HIV/AIDS reports20 Mar 2026
Latest
1 in 12 monthsCurrent HIV/AIDS Reports
Cytomegalovirus in HIV: A Modifiable Driver of Inflammation, Frailty, and Aging
ReviewInflammation